...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF up 290% to $0.16...question

Even though my shares seem to be tradeable as ZHCLF, I'm not convinced the are the same. Who would sell this low given buyout rumors are really picking up again.

 

 

 

 

Share
New Message
Please login to post a reply